Stay updated on PLATFORM Clinical Trial: Maintenance for Oesophago-gastric Cancer
Sign up to get notified when there's something new on the PLATFORM Clinical Trial: Maintenance for Oesophago-gastric Cancer page.

Latest updates to the PLATFORM Clinical Trial: Maintenance for Oesophago-gastric Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new drug names such as Rucaparib and Ramucirumab, and the removal of detailed descriptions regarding the trial's methodology and eligibility criteria for patients with oesophago-gastric adenocarcinomas.SummaryDifference47%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check100 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to PLATFORM Clinical Trial: Maintenance for Oesophago-gastric Cancer
Enter your email address, and we'll notify you when there's something new on the PLATFORM Clinical Trial: Maintenance for Oesophago-gastric Cancer page.